Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.04 CAD
Change Today 0.00 / 0.00%
Volume 0.0
CYX On Other Exchanges
Symbol
Exchange
Venture
OTC US
Frankfurt
As of 9:33 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

calyx bio-ventures inc (CYX) Snapshot

Open
C$0.04
Previous Close
C$0.04
Day High
C$0.04
Day Low
C$0.04
52 Week High
09/3/14 - C$0.07
52 Week Low
12/16/14 - C$0.02
Market Cap
1.7M
Average Volume 10 Days
24.9K
EPS TTM
C$-0.01
Shares Outstanding
47.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CALYX BIO-VENTURES INC (CYX)

Related News

No related news articles were found.

calyx bio-ventures inc (CYX) Related Businessweek News

No Related Businessweek News Found

calyx bio-ventures inc (CYX) Details

Calyx Bio-Ventures Inc., a development stage company, provides technology solutions to indoor agriculture. It owns a portfolio of proprietary intellectual property with applications in crop enhancement. The company, through its subsidiary, Cannigistics Agri-Solutions Corp., also offers a software platform to enhance indoor agricultural operations. Calyx Bio-Ventures Inc. is headquartered in Vancouver, Canada.

calyx bio-ventures inc (CYX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

calyx bio-ventures inc (CYX) Key Developments

Calyx Bio-Ventures Inc. Announces Management Appointments

Calyx Bio-Ventures Inc. announced the appointment of Roger Forde as President & CEO of Calyx, effective immediately. Mr. Forde was elected to the board of directors at the meeting, and is also the founder of the company's wholly-owned subsidiary, Cannigistics Agri-Solutions Corp. Mr. Forde has worked in the computer and telecom industries for more than 30 years. The company also announced the appointment of Gavin McMillan as CFO of Calyx, effective immediately. Mr. McMillan was also elected to the board of directors at the Meeting. Mr. McMillan has over twenty years of business experience, including in the roles of President & CEO and as a director of publicly listed companies. In addition to his experience in executive positions for reporting issuers, he has been directly responsible for managing and growing multi-million dollar lines of business, overseeing measurement, reporting, and financing.

Calyx Bio-Ventures Inc. Proposes Amendment to Articles

Calyx Bio-Ventures Inc. will propose amendment to Articles to include Advance Notice Provisions at the annual general and special meeting to be held on June 12, 2015.

Calyx Bio-Ventures Inc., Annual General Meeting, Jun 12, 2015

Calyx Bio-Ventures Inc., Annual General Meeting, Jun 12, 2015., at 14:00 Pacific Standard Time. Location: Suite 2200. Agenda: To fix the number of directors at four; to elect directors for the ensuing year; to appoint Dale Matheson Carr-Hilton Labonte LLP, as auditor of the company for the ensuing year; to authorize the directors to determine the remuneration to be paid to the auditor; to confirm the company's stock option plan, as required annually by the policies of the TSX Venture Exchange, as more particularly set out in the section of the information circular entitled "Particulars of Matters to be Acted Upon ­ Confirming Stock Option Plan"; to consider and, if deemed appropriate, approve by special resolution, the alteration of the company's Articles to include advance notice provisions, as more particularly set out in the section of the information circular entitled "Particulars of Matters to be Acted Upon ­ Approval of Amendment to Articles to include Advance Notice Provisions"; and to transact such other business as may properly be put before the Meeting.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYX:CN C$0.04 CAD 0.00

CYX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CYX.
View Industry Companies
 

Industry Analysis

CYX

Industry Average

Valuation CYX Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CALYX BIO-VENTURES INC, please visit www.calyxbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.